The rising awareness about the cost-effectiveness of OTC drugs to fuel the Latin America over the Counter (OTC) Drugs Market growth Overview: Dietary supplements contain dietary ingredients that are employed to supply nutrients to the body to satisfy the nutrient balance of the body. Whereas on the opposite hand, over-thecounter medicine is observed as non-prescription medicines, as these is also availed without having a prescriptions. OTC medicines are safe if they are administered per the directions provided by tending professionals. In addition, they are a source of non-nutrient chemicals, which provide biological profit to the body. View sample and decide: https://www.marketdataforecast.com/market-reports/latin-americaover-the-counter-drugs-market-513/request-sample The Latin America Over The Counter (OTC) Drugs Market has been valued at USD 8,942.1 Million in 2016 and is projected to achieve USD 14,701.7 Million by 2022, at a CAGR of 8.64%. The growing trend among individuals to choose out OTC medication for minor diseases across the countries of the region is additionally scripted to supplements the market growth. To know more read: https://www.marketdataforecast.com/market-reports/latin-america-overthe-counter-drugs-market-513/ Drivers and Restraints: When nicotine replacement therapies became over-the-counter medication, the sales enhanced nearly by double within the first year alone post the notification concerning the switch. Its accrued access enabled thousands of individuals to use these therapies to quit smoking. Heartburn reducers have successfully helped shoppers save an average of $ 160 annually in prescription spending and doctor consultations. As the pharmaceutical business has matured, patients became a lot concerned in health-care problems and currently have taken some medical treatment into their own hands. The rise within the variety of retail stores within the pharmaceutical business and shift in the focus of many companies towards concentrating on hypermarkets and grocery stores as distribution channels for medication can aid the market’s growth within the region. Get your customized report: https://www.marketdataforecast.com/market-reports/latinamerica-over-the-counter-drugs-market-513/customize-report Geographical Segmentation: On the concept of geography, the Latin America market is examined as varied regions like Brazil, Argentina, and Mexico. The increasing health care costs is positively calculated to steer to the patients in selecting over the counter medication rather than consulting physicians, which can definitely fuel the market growth. The top market players on the regional market scape include laxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda. Related Links: Latin America In-Vitro Diagnostics Market: https://www.marketdataforecast.com/marketreports/latin-america-in-vitro-diagnostics-market-150/ Latin America Nuclear Medicine Radiopharmaceuticals Market: https://www.marketdataforecast.com/market-reports/latin-america-nuclear-medicineradiopharmaceuticals-market-133/ About MarketDataForecast™Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626

The OTC drugs market in Latin America region has been estimated at USD 8,942.1 Million in 2016 and is projected to reach USD 14,701.7 Million by 2022, at a CAGR of 8.64% during the forecast period from 2016 to 2022. Brazil, Mexico and Argentina are the leading contributors to the Latin America OTC drugs market